IRIS
ROSSI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.271
EU - Europa 7.947
AS - Asia 4.949
SA - Sud America 1.215
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 4
Totale 22.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.116
IE - Irlanda 2.604
SG - Singapore 1.466
HK - Hong Kong 1.332
DE - Germania 1.313
CN - Cina 1.083
UA - Ucraina 1.024
BR - Brasile 963
SE - Svezia 960
FI - Finlandia 602
RU - Federazione Russa 588
VN - Vietnam 531
IT - Italia 406
IN - India 188
GB - Regno Unito 160
AR - Argentina 113
KR - Corea 90
CA - Canada 87
FR - Francia 76
MX - Messico 50
ID - Indonesia 49
BD - Bangladesh 42
ZA - Sudafrica 42
EC - Ecuador 41
EU - Europa 38
IR - Iran 37
PL - Polonia 35
JP - Giappone 31
AT - Austria 28
NL - Olanda 28
PY - Paraguay 26
CO - Colombia 25
BE - Belgio 24
CZ - Repubblica Ceca 23
ES - Italia 23
TR - Turchia 19
VE - Venezuela 18
IQ - Iraq 16
LT - Lituania 16
CL - Cile 13
MA - Marocco 10
RO - Romania 9
PK - Pakistan 8
IL - Israele 7
KE - Kenya 7
UY - Uruguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
PE - Perù 6
AL - Albania 5
BG - Bulgaria 5
BJ - Benin 5
CH - Svizzera 5
DZ - Algeria 5
HN - Honduras 5
HR - Croazia 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
AM - Armenia 3
AZ - Azerbaigian 3
KG - Kirghizistan 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GR - Grecia 2
GY - Guiana 2
JM - Giamaica 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TO - Tonga 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NG - Nigeria 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TC - Turks e Caicos 1
Totale 22.512
Salva come PNG Salva come JPEG
Città #
Dublin 2.604
Jacksonville 1.898
Hong Kong 1.331
Dearborn 1.007
Wilmington 700
Singapore 523
Beijing 480
Chandler 379
Ashburn 345
Lawrence 339
Princeton 339
San Mateo 256
Moscow 246
Ho Chi Minh City 198
Los Angeles 190
Andover 177
Ann Arbor 167
Buffalo 155
Piemonte 146
Hanoi 115
Boardman 92
Seoul 90
São Paulo 90
Hefei 77
Nanjing 72
Redondo Beach 71
Houston 65
Kunming 65
Woodbridge 64
New York 57
Dallas 56
Munich 50
Bremen 47
Norwalk 43
Novara 40
Guangzhou 38
Rio de Janeiro 35
Frankfurt am Main 33
Helsinki 33
Grafing 32
Düsseldorf 31
Jinan 31
Montreal 30
Seattle 30
Toronto 29
Tokyo 28
Warsaw 26
Denver 25
Atlanta 24
London 24
Nanchang 24
Belo Horizonte 23
Brussels 23
Poplar 21
Santa Clara 21
Chennai 19
Fairfield 19
Mexico City 19
Milan 19
Tianjin 19
Nuremberg 18
Stockholm 18
Zanjan 18
Brno 17
Haiphong 17
Orem 17
Phoenix 17
Thái Bình 17
Turku 17
Curitiba 16
Johannesburg 16
Biên Hòa 15
Chicago 15
Shenyang 15
Brooklyn 14
Da Nang 14
Guayaquil 14
Ninh Bình 14
Boston 13
Leawood 13
Thái Nguyên 13
Dhaka 12
Fuzhou 12
Manaus 12
San Francisco 12
Vercelli 12
Vienna 12
Asunción 11
Mumbai 11
Porto Alegre 11
Santo André 11
Amsterdam 10
Ankara 10
Berlin 10
Cape Town 10
Fortaleza 10
Manchester 10
Quito 10
Wuhan 10
Bắc Ninh 9
Totale 13.763
Salva come PNG Salva come JPEG
Nome #
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 159
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 142
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 139
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 131
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 126
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 124
The clinical implications of gene mutations in chronic lymphocytic leukaemia 123
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 122
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 120
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 116
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 114
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 113
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 113
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 112
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 107
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 106
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 106
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 106
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 105
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 104
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 104
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 104
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 103
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 103
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 102
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 101
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 100
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 100
Absence of NOTCH1 gene mutations in MALT lymphomas 99
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 99
Biology and treatment of Richter syndrome 98
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 98
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 97
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 96
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 95
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 95
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 95
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 94
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 93
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 93
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 93
The genetics of nodal marginal zone lymphoma 93
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 92
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 92
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 92
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 91
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 91
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 91
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 90
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 90
Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report 89
Cryoglobulin-induced IL-1 beta gene expression and procytokine in monocytes from cryoglobulinemic patients. 87
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 87
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 87
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 86
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 86
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 86
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 86
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 85
Renal handling of monoclonal free light chains depends on fractional excretion: study on 1039 serum-urine paired samples of 187 patients 85
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 85
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 84
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 83
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 83
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 83
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 82
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 82
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 82
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 82
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. 81
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 81
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 80
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 80
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma 80
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 80
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment 80
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 80
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 80
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 80
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 79
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia 79
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 79
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 79
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 79
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 78
Richter syndrome and fludarabine: a controversial relationship 77
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia 77
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 77
Analysis of the coding genome of diffuse large B-cell lymphoma 77
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations 77
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 76
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib 75
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia 75
MOLECULAR ANALYSIS OF IMMUNOGLOBULIN VARIABLE GENES IN HIV-RELATED NON HODGKIN LYMPHOMA REVEALS IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS 75
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 75
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia 74
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 74
Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development 74
Totale 9.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.071 0 0 0 0 0 20 328 21 332 20 339 11
2021/20221.959 24 12 284 193 154 15 209 31 154 57 363 463
2022/20234.202 356 132 213 60 154 321 98 177 2.532 5 95 59
2023/20241.217 74 68 82 22 238 15 256 29 5 5 81 342
2024/20253.295 63 10 68 40 93 218 279 246 1.221 418 103 536
2025/20264.478 425 392 1.002 1.744 753 162 0 0 0 0 0 0
Totale 22.879